15.7 C
Munich

EU drug regulator intends to provide advice on J&J COVID staff

LONDON (AP) – Experts from the European Medicines Agency are set to release their findings later on Tuesday into possible links between son onson և and onson coronavirus vaccines արտ unusual condensation disorders found in the United States.

Last week, J&J stopped distributing its single-dose vaccine in Europe after the US Food and Drug Administration advised officials to stop using it until rare tissue cases were investigated. Officials find six extremely unusual cases of blood clots in nearly 7 million people in the United States

J&J has advised European governments to keep their doses until the EU regulator gives instructions on how to use them. The widespread use of gunpowder in Europe has not yet begun!

The delay was a further blow to vaccination efforts in the European Union, which suffered from shortages of supplies, logistical problems and unusual blood tissue concerns, as well as the small number of people who received the AstraZeneca COVID-19 vaccine. Experts worry that a temporary cessation of J&J shooting could further undermine vaccine confidence and complicate global COVID-19 immunization efforts.

South Africa stopped using the vaccine last week after the US shutdown, with countries including Italy, Romania, the Netherlands, Denmark and Croatia maintaining their J&J doses.

Blood transfusions associated with the J&J vaccine occur in unusual parts of the body, such as veins that drain from the brain. These patients also have abnormally low blood platelet counts, a condition that is usually associated with bleeding rather than thickening.

Scientists in Norway and Germany using the AstraZeneca vaccine have suggested that some people respond to an abnormal immune system by making antibodies that attack their own platelets.

It is unknown at this time what he will do after leaving the post. But both J&J and AstraZeneca vaccines, as well as Russian COVID-19 vaccines, one from China, are made using the same technology. They train the immune system to understand the stem cell protein that covers the coca virus. To do this, they use a cold virus called adenovirus to carry the spike gene into the body.

Earlier this month, the EU drug regulator said there was a “possible link” between the AstraZeneca shot, a “rare blood clot”, but said the benefits of the vaccine far outweighed the risks of COVID-19. It notes that the risk is lower than the risk of blood clots that healthy women face from birth control pills.

[]

LEAVE A REPLY

Please enter your comment!
Please enter your name here